Literature DB >> 24467563

Aditya Jyot-Diabetic Retinopathy in Urban Mumbai Slums Study (AJ-DRUMSS): study design and methodology - report 1.

Mohan Sunita1, Shachi Desai, Prasad Vinay, Samita Moolani, Navendu Rai, Sheth Deepen, Rogiye Ashwini, Sonawane Manish, Gawali Hemangi, Oliullah Abdal, Pandurang Kulkarni, Arindam Chakravarti, Satagopan Uthra, Rajiv Raman, Srinivasan Radhika, Sundaram Natarajan, Govindasamy Kumaramanickavel, Catherine McCarty.   

Abstract

PURPOSE: To describe the methodology of Aditya Jyot-Diabetic Retinopathy in Urban Mumbai Slums Study (AJ-DRUMSS), which was designed (i) to estimate the prevalence of diabetic retinopathy (DR) in a general population, (ii) to study the risk factors associated with DR in those with type 2 diabetes mellitus (DM), and (iii) to create awareness for early detection and develop timely interventional management for DR.
METHODS: AJ-DRUMSS is an ongoing population-based cross sectional study conducted in seven wards of slums in Mumbai, India, wherein eligible subjects from the general population were screened for DR and profiled for their demographic, social and biochemical parameters to study the associations of these factors.
RESULTS: To date, nearly 54,000 households have been enumerated for both awareness and DR prevalence in five study areas (out of seven) during 17 awareness campaigns and 78 DR screening camps. Of these, 4295 households were included in AJ-DRUMSS. Nearly 15,000 camp subjects (including subjects from awareness-focused areas who also turned up for the screening camps) were screened from the total enumerated households, of which 16.1% were diagnosed with type 2 DM. A total of 14.5% of these had evidence of DR and 3.5% had sight-threatening DR.
CONCLUSIONS: A detailed study design of AJ-DRUMSS is described. In the screening camps nearly 3.5% of the diabetic population had sight-threatening DR, which needed an active interventional strategy. This study will help in formulating efficient eye care policies, making optimum use of available resources, reorienting healthcare providers and the ignorant within the population regarding the need for periodic ophthalmic surveillance and timely intervention.

Entities:  

Mesh:

Year:  2014        PMID: 24467563     DOI: 10.3109/09286586.2013.867509

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  6 in total

Review 1.  Prevalence of type 2 diabetes and its complications in India and economic costs to the nation.

Authors:  R Pradeepa; V Mohan
Journal:  Eur J Clin Nutr       Date:  2017-04-19       Impact factor: 4.016

2.  Ischemia modified albumin as a useful marker for diagnoses and management of diabetic retinopathy.

Authors:  Winay Kumar; Russell Seth Martins; Nargis Anjum; Syeda Sadia Fatima
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

3.  Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India.

Authors:  Ramachandran Rajalakshmi; Umesh C Behera; Harsha Bhattacharjee; Taraprasad Das; Clare Gilbert; G V S Murthy; Hira B Pant; Rajan Shukla
Journal:  Indian J Ophthalmol       Date:  2020-02       Impact factor: 1.848

4.  Regional variation in diabetic retinopathy and associated factors in Spectrum of Eye Disease in Diabetes (SPEED) study in India-Report 5.

Authors:  Taraprasad Das; Gudlavalleti V S Murthy; Hira B Pant; Clare Gilbert; Ramachandran Rajalakshmi; Umesh C Behera
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

5.  Estimating the proportion of persons with diabetes developing diabetic retinopathy in India: A systematic review and meta-analysis.

Authors:  A T Jotheeswaran; Nukala Lovakanth; Shruthi Nadiga; Raghupathy Anchala; G V S Murthy; Clare E Gilbert
Journal:  Indian J Endocrinol Metab       Date:  2016-04

6.  Prevalence and risk factors of diabetic retinopathy among an elderly population with diabetes in Nepal: the Bhaktapur Retina Study.

Authors:  Raba Thapa; Shankha N Twyana; Govinda Paudyal; Shankar Khanal; Ruth van Nispen; Stevie Tan; Suman S Thapa; Ghmb van Rens
Journal:  Clin Ophthalmol       Date:  2018-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.